Table 3.
Pre and post bone morphogenic protein analysis of VRT, SMT and control group.
| Sr. no | Variable | VRT Mean and SD |
SMT Mean and SD |
Control Mean and SD |
P-value | |
|---|---|---|---|---|---|---|
| 1 | BMP-2 (pg/ml) | Base line | 657.12 ± 8.1 | 656.33 ± 8.9 | 656.22 ± 8.5 | 0.935 |
| 4 weeks | 656.45 ± 7.1 | 656.22 ± 7.2 | 655.72 ± 7.1 | 0.946 | ||
| 8 weeks | 656.45 ± 7.2 | 656.01 ± 7.3 | 655.48 ± 9.2 | 0.928 | ||
| 3 months | 655.92 ± 7.5 | 656.23 ± 7.4 | 655.28 ± 9.8 | 0.934 | ||
| P-value | 0.967 | 0.999 | 0.987 | |||
| 2 | BMP-4 (pg/ml) | Base line | 643.21 ± 7.9 | 643.66 ± 7.8 | 642.89 ± 7.6 | 0.951 |
| 4 weeks | 642.88 ± 7.2 | 642.58 ± 7.6 | 642.28 ± 7.4 | 0.967 | ||
| 8 weeks | 642.43 ± 7.3 | 642.45 ± 7.2 | 642.15 ± 7.4 | 0.989 | ||
| 3 months | 642.15 ± 7.6 | 642.11 ± 7.5 | 642.03 ± 7.9 | 0.984 | ||
| P-value | 0.971 | 0.923 | 0.841 | |||
| 3 | BMP-6 (pg/ml) | Base line | 698.88 ± 9.2 | 699.78 ± 9.4 | 698.76 ± 9.5 | 0.931 |
| 4 weeks | 698.57 ± 8.5 | 699.46 ± 8.3 | 698.59 ± 8.5 | 0.930 | ||
| 8 weeks | 698.36 ± 8.2 | 699.35 ± 8.3 | 698.28 ± 8.3 | 0.901 | ||
| 3 months | 698.12 ± 8.1 | 699.12 ± 8.2 | 698.11 ± 8.3 | 0.904 | ||
| P-value | 0.993 | 0.994 | 0.995 | |||
| 4 | BMP-7 (pg/ml) | Base line | 241.32 ± 8.3 | 240.57 ± 8.2 | 241.33 ± 8.3 | 0.946 |
| 4 weeks | 241.22 ± 7.5 | 240.33 ± 6.3 | 240.81 ± 7.5 | 0.924 | ||
| 8 weeks | 240.92 ± 7.3 | 239.97 ± 6.8 | 240.49 ± 7.3 | 0.915 | ||
| 3 months | 240.88 ± 7.4 | 239.68 ± 7.3 | 240.34 ± 7.4 | 0.977 | ||
| P-value | 0.997 | 0.980 | 0.930 | |||
VRT virtual reality training, SMT sensory motor training, BMP bone morphogenic proteins, SD standard deviation.